Parkinson's Patient Engagement
9zest digital therapy solutions for people with debilitating conditions.
9zest disrupts how therapy is delivered to patients with debilitating conditions, such as Stroke, Parkinson's, and Chronic Pain. 9zest uses Al powered, mobile app delivered tele-therapy solution. The solution enhances the quality of life. Clinical and contextual evidence support that the non-pharmalogic multidisciplinary therapy intervention is feasible, safe, effective; and promotes compliance, recovery and well-being.
* 9zest apps are FDA Registered Class II Medical Devices * The technology leverages Al and mHealth platform to deliver tailored therapy specific to the patient's symptoms * 5 Clinical Trials underway with the 9zest apps in USA and Canada *A recently concluded, NI H funded clinical trial, published in the journal of the Neurological Sciences show significant improvement using the 9zest Stroke Therapy App. * 9zest uses nonpharmalogic, multidisciplinary therapies including Physical Therapy, Occupational Therapy, Speech Therapy,Fitness,Yoga and Meditation. * 9zest support adjunct therapy to ameliorate often associated chronic pain * 9zest provision self and therapist assisted modes * Apps are commercially available on Android and iOs * 9zest apps have builtin tools to - Dynamically adapt therapy to the improved condition of the patient - Measure health progression - Keep patients motivated with social engineering, encouragements and peer-competition. We are seeking the fund to scale the business.
Company name: 9zest, Inc.
Date founded: November 2015
Contact: Manoj Agarwala, CEO | Sam Majmundar, CBDO
Call 617.863.0108 to inquire
Funding to date: $1.6 million
Financing sought: $2 million
Current investors: Founders, F&F
Website URL: www.9zest.com
Pitch URL: N/A